These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8626123)

  • 1. Recurrence patterns in locally advanced cervical carcinoma: role of nodal status and 72-kDa metalloproteinase index.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Romanini C; Biagini G
    Gynecol Oncol; 1996 Apr; 61(1):83-9. PubMed ID: 8626123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 72-kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Romanini C; Biagini G
    Gynecol Oncol; 1996 Feb; 60(2):271-6. PubMed ID: 8631550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
    Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
    Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
    Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery.
    McLellan R; Dillon MB; Woodruff JD; Heatley GJ; Fields AL; Rosenshein NB
    Gynecol Oncol; 1994 Feb; 52(2):253-9. PubMed ID: 8314148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
    Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
    Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIB 1 immunostaining in stage I squamous cervical carcinoma: relationship with natural killer cell activity.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; de Nictolis M; Muzzioli M; Fabris N; Romanini C; Biagini G
    Gynecol Oncol; 1995 Jul; 58(1):28-33. PubMed ID: 7789886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
    Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
    Kristensen GB; Holm R; Abeler VM; Tropé CG
    Gynecol Oncol; 1996 Jun; 61(3):378-83. PubMed ID: 8641619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of early stage cervical carcinoma at Leids University Medical Center, 1984-1996: depth of invasion, number and bilaterality of metastatic lymph nodes prognostic for recurrence].
    Hellebrekers BW; Zwinderman AH; Kenter GG; Peters AA; Fleuren GJ; Trimbos JB
    Ned Tijdschr Geneeskd; 2000 Nov; 144(48):2304-9. PubMed ID: 11143298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.